{"product_id":"global-interventional-pulmonology-market-size-study-forecast-by-product-bronchoscopes-electromagnetic-navigation-bronchoscopy-system-pleuroscopes-respiratory-endotherapy-devices-airway-stents-pleural-catheters-endobronchial-valves-bronchial-the","title":"Global Interventional Pulmonology Market Size Study \u0026 Forecast, by Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial The","description":"\u003cp\u003eGlobal Interventional Pulmonology Market Size Study \u0026amp; Forecast, by Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems), by Indication (Asthma, COPD, Lung Cancer, Tracheal and Bronchial Stenosis, Others), by End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others), and Regional Analysis, 2023-2030\u003cbr\u003e\nGlobal Interventional Pulmonology Market is valued at approximately USD 3.95 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2023-2030. Interventional pulmonology is a medical specialty that focuses on the detection and treatment of different illnesses and ailments which impact the respiratory system, particularly the lungs, and airways. Advanced endoscopic methods and minimally invasive treatments are used in this new and rapidly evolving field to offer diagnostic and therapeutic approaches for patients with lung and airway problems. The rising inclination towards the minimally invasive nature of procedures, growing emphasis on early diagnosis and screening, rising geriatric population, and favorable reimbursement policies are the major factors that are fueling the market demand across the globe.\u003c\/p\u003e\n\n\u003cp\u003eThe rising prevalence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and various pulmonary infections has led to a growing demand for interventional pulmonology procedures. According to the World Health Organization, in 2020, it was estimated that nearly 2.21 million new cases of trachea, bronchus, and lung cancer were recorded globally, which is projected to rise and is likely to reach 3.63 million new cases by 2040. As these conditions become more prevalent, the need for minimally invasive diagnostic and therapeutic interventions provided by interventional pulmonology increases. Thus, these aforementioned factors are propelling the growth of the Interventional Pulmonology Market during the estimated period. Moreover, the increasing technological advancements in endoscopic techniques, as well as the ongoing research and development activities present various lucrative opportunities over the forecast years. However, the high cost of procedures and equipment and the dearth of specialized training and expertise are challenging the market growth throughout the forecast period of 2023-2030.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Interventional Pulmonology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East \u0026amp; Africa. North America dominated the market in 2022 owing to the increasing technological developments related to endoscopic procedures, and a shift towards minimally invasive surgery in developed nations such as the U.S. Additionally, the escalation of air pollution and the prevalence of lung disorders brought on by heavy smoking are significant market development factors. Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing aging population, rising healthcare spending, and improvements in lung disease diagnosis and treatment are significantly propelling the market demand across the region.\u003c\/p\u003e\n\n\u003cp\u003eMajor market players included in this report are:\u003cbr\u003e\nArgon Medical Systems LLP\u003cbr\u003e\nBody Vision Medical Ltd.\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nC. R. Bard, Inc. (Becton, Dickinson and Company)\u003cbr\u003e\nCONMED Corporation\u003cbr\u003e\nENDO-FLEX GmbH\u003cbr\u003e\nFujifilm Corporation\u003cbr\u003e\nKARL STORZ SE \u0026amp; Co. KG\u003cbr\u003e\nMedtronic\u003cbr\u003e\nOlympus Corporation\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\nIn April 2021, Olympus Corporation unveiled the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a range of five premium endoscopes for use in innovative diagnostic and therapeutic procedures, have been added to Olympus Corporation's U.S. bronchoscopy portfolio.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Interventional Pulmonology Market Report Scope:\u003cbr\u003e\nHistorical Data – 2020 - 2021\u003cbr\u003e\nBase Year for Estimation – 2022\u003cbr\u003e\nForecast period - 2023-2030\u003cbr\u003e\nReport Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered - Product, Indication, End-user, Region\u003cbr\u003e\nRegional Scope - North America; Europe; Asia Pacific; Latin America; Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Product:\u003cbr\u003e\nBronchoscopes\u003cbr\u003e\nElectromagnetic Navigation Bronchoscopy System\u003cbr\u003e\nPleuroscopes\u003cbr\u003e\nRespiratory Endotherapy Devices\u003cbr\u003e\nAirway Stents\u003cbr\u003e\nPleural Catheters\u003cbr\u003e\nEndobronchial Valves\u003cbr\u003e\nBronchial Thermoplasty Systems\u003c\/p\u003e\n\n\u003cp\u003eBy Indication:\u003cbr\u003e\nAsthma\u003cbr\u003e\nCOPD\u003cbr\u003e\nLung Cancer\u003cbr\u003e\nTracheal and Bronchial Stenosis\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy End-user:\u003cbr\u003e\nHospitals\u003cbr\u003e\nAmbulatory Surgical Centers\u003cbr\u003e\nDiagnostic Centers\u003cbr\u003e\nSpecialty Clinics\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa\u003cbr\u003e\nSaudi Arabia\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nRest of Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\n\u003cp\u003eCompanies Mentioned\u003cbr\u003e\nArgon Medical Systems LLP\u003cbr\u003e\nBody Vision Medical Ltd.\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nC. R. Bard, Inc. (Becton, Dickinson and Company)\u003cbr\u003e\nCONMED Corporation\u003cbr\u003e\nENDO-FLEX GmbH\u003cbr\u003e\nFujifilm Corporation\u003cbr\u003e\nKARL STORZ SE \u0026amp; Co. KG\u003cbr\u003e\nMedtronic\u003cbr\u003e\nOlympus Corporation\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 200 Pages \/ MCW16251331","offer_id":47648898285874,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-interventional-pulmonology-market-size-study-forecast-by-product-bronchoscopes-electromagnetic-navigation-bronchoscopy-system-pleuroscopes-respiratory-endotherapy-devices-airway-stents-pleural-catheters-endobronchial-valves-bronchial-the","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}